JPWO2022138826A1 - - Google Patents
Info
- Publication number
- JPWO2022138826A1 JPWO2022138826A1 JP2022531600A JP2022531600A JPWO2022138826A1 JP WO2022138826 A1 JPWO2022138826 A1 JP WO2022138826A1 JP 2022531600 A JP2022531600 A JP 2022531600A JP 2022531600 A JP2022531600 A JP 2022531600A JP WO2022138826 A1 JPWO2022138826 A1 JP WO2022138826A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022128183A JP2022160664A (ja) | 2020-12-24 | 2022-08-10 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020215231 | 2020-12-24 | ||
| JP2020215231 | 2020-12-24 | ||
| JP2021146903 | 2021-09-09 | ||
| JP2021146903 | 2021-09-09 | ||
| PCT/JP2021/047886 WO2022138826A1 (ja) | 2020-12-24 | 2021-12-23 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022128183A Division JP2022160664A (ja) | 2020-12-24 | 2022-08-10 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022138826A1 true JPWO2022138826A1 (https=) | 2022-06-30 |
| JP7124248B1 JP7124248B1 (ja) | 2022-08-23 |
| JPWO2022138826A5 JPWO2022138826A5 (https=) | 2022-12-05 |
Family
ID=82158673
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022531600A Active JP7124248B1 (ja) | 2020-12-24 | 2021-12-23 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
| JP2022128183A Pending JP2022160664A (ja) | 2020-12-24 | 2022-08-10 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022128183A Pending JP2022160664A (ja) | 2020-12-24 | 2022-08-10 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240074973A1 (https=) |
| EP (1) | EP4268827A4 (https=) |
| JP (2) | JP7124248B1 (https=) |
| KR (1) | KR20230124624A (https=) |
| AU (1) | AU2021410145A1 (https=) |
| TW (1) | TW202241449A (https=) |
| WO (1) | WO2022138826A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025205960A1 (ja) * | 2024-03-27 | 2025-10-02 | 参天製薬株式会社 | エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536816A (en) * | 1964-09-30 | 1970-10-27 | Atlas Chem Ind | Water-in-oil emulsion |
| US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| KR20050092429A (ko) | 2003-01-22 | 2005-09-21 | 니찌방 가부시기가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법 |
| US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
| JP5021155B2 (ja) * | 2003-08-01 | 2012-09-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物 |
| WO2005089803A2 (en) * | 2004-03-24 | 2005-09-29 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs |
| CN101217948A (zh) | 2005-07-08 | 2008-07-09 | 千寿制药株式会社 | 包含依匹那丁的透皮吸收眼科制剂 |
| CN101036659A (zh) * | 2006-03-13 | 2007-09-19 | 张文静 | 一组盐酸依匹斯汀制剂及其制备方法 |
| EP2056809A1 (en) * | 2006-08-28 | 2009-05-13 | Senju Pharmaceutical Co., Ltd. | Ophthalmic percutaneous absorption type preparation |
| US20080194544A1 (en) * | 2007-02-08 | 2008-08-14 | Ramesh Krishnamoorthy | Aqueous formulations of epinastine for treating allergic rhinitis |
| KR20240023714A (ko) * | 2015-02-02 | 2024-02-22 | 산텐 세이야꾸 가부시키가이샤 | 폴리아프론 및 이의 안검 투여 |
| JP6134853B1 (ja) * | 2016-10-28 | 2017-05-24 | 参天製薬株式会社 | エピナスチン含有点眼液 |
| JP7355539B2 (ja) * | 2018-07-20 | 2023-10-03 | ロート製薬株式会社 | 眼科組成物 |
| JP7458159B2 (ja) * | 2018-09-28 | 2024-03-29 | ロート製薬株式会社 | 眼科組成物 |
-
2021
- 2021-12-23 US US18/269,474 patent/US20240074973A1/en active Pending
- 2021-12-23 WO PCT/JP2021/047886 patent/WO2022138826A1/ja not_active Ceased
- 2021-12-23 EP EP21910965.9A patent/EP4268827A4/en active Pending
- 2021-12-23 TW TW110148529A patent/TW202241449A/zh unknown
- 2021-12-23 JP JP2022531600A patent/JP7124248B1/ja active Active
- 2021-12-23 AU AU2021410145A patent/AU2021410145A1/en active Pending
- 2021-12-23 KR KR1020237024025A patent/KR20230124624A/ko active Pending
-
2022
- 2022-08-10 JP JP2022128183A patent/JP2022160664A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022138826A1 (ja) | 2022-06-30 |
| JP7124248B1 (ja) | 2022-08-23 |
| TW202241449A (zh) | 2022-11-01 |
| EP4268827A4 (en) | 2024-12-11 |
| JP2022160664A (ja) | 2022-10-19 |
| US20240074973A1 (en) | 2024-03-07 |
| KR20230124624A (ko) | 2023-08-25 |
| AU2021410145A1 (en) | 2023-07-27 |
| AU2021410145A9 (en) | 2024-07-25 |
| EP4268827A1 (en) | 2023-11-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220527 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220527 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220527 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220712 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220810 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7124248 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |